Cadre Holdings, Inc. (CDRE) stock

CDRENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 15/3015% above fair value

$33.42+0.34 (+1.03%)

Close on Nov 13, 2026Market cap $1.43BP/E 36.7Yield 1.14%

Cadre statistics

108 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 9, 2027 (estimated, during market hours)
Last ex-dividend date: Jul 31, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.43B; $498.53M
Enterprise Value: $1.74B; $433.11M
PE Ratio: 36.73; 29.52
PS Ratio: 1.95; 2.94
PB Ratio: 3.90; 3.24
P/FCF Ratio: 18.74; 26.31
P/OCF Ratio: 16.11; 21.97

Enterprise valuationIndustry

EV / Sales: 2.37; 2.60
EV / EBITDA: 17.06; 18.41
EV / EBIT: 22.05; 24.14
EV / FCF: 22.74; 27.51

Share statisticsIndustry

Shares Outstanding: 43M; 43M
Shares Change (YoY): 10.5%; 3.32%
Shares Change (QoQ): 0.23%; 0.20%
Float: 31M; 37M
Shares Held by Insiders: 27.7%; 10.5%
Shares Held by Institutions: 78.1%; 60.5%

Short sellingIndustry

Short Interest: 2M; –
Short Interest Change: 13.8%; -2.57%
Short % of Float: 6.93%; 5.11%
Short % of Shares Outstanding: 5.01%; 3.98%
Days to Cover: 4.55; 3.94

Stock price statisticsIndustry

52-Week High: $48.76; –
52-Week Low: $24.07; –
20-Day Moving Average: $31.03; –
50-Day Moving Average: $28.32; –
200-Day Moving Average: $31.72; –
Average True Range (14): $1.35; –
Price Change (1 Week): 2.52%; 0.99%
Price Change (1 Month): 28.9%; -3.52%
Price Change (3 Months): 0.36%; -7.86%
Price Change (6 Months): 12.2%; -1.12%
Price Change (YTD): -18.2%; -2.92%
Price Change (1 Year): -22.7%; -1.37%
Price Change (3 Years): 3.66%; 3.24%
Price Change (5 Years): 68.2%; -50.4%
Average Volume (10 Days): 390,211; –
Average Volume (20 Days): 429,480; –
Average Volume (90 Days): 432,936; –
Relative Volume: 0.78; 0.76
Relative Strength Index (14): 66.9; 46.7
Volatility (1 Year): 47.9%; 64.2%
Beta (5 Years): 1.01; 1.04

MarginsIndustry

Gross Margin: 42.0%; 55.9%
Operating Margin: 10.7%; -5.12%
Pretax Margin: 8.37%; -2.32%
Profit Margin: 5.61%; -9.29%
EBITDA Margin: 13.9%; -2.52%
FCF Margin: 10.4%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): 11.6%; -17.3%
Return on Assets (ROA): 4.79%; -12.3%
Return on Invested Capital (ROIC): 9.00%; -2.83%
Return on Capital Employed (ROCE): 10.2%; -8.13%

Financial positionIndustry

Current Ratio: 2.35; 2.49
Quick Ratio: 1.26; 1.53
Debt / Equity: 1.01; 0.42
Debt / EBITDA: 3.63; 2.23
Debt / FCF: 4.84; 3.62
Net Debt / EBITDA: 3.00; 1.49

GrowthIndustry

Revenue Growth (YoY): 18.3%; 9.42%
Net Income Growth (YoY): -9.42%; 13.4%
EPS Growth (YoY): -18.8%; 15.1%
FCF Growth (YoY): 24.6%; 7.64%
Revenue Growth (3Y CAGR): 10.1%; 7.08%
Revenue Growth (5Y CAGR): 8.57%; 11.8%
EPS Growth (3Y CAGR): 85.4%; 3.11%
EPS Growth (5Y CAGR): -6.14%; 7.64%

EfficiencyIndustry

Asset Turnover: 0.85; 0.59
Inventory Turnover: 3.56; 2.20
Revenue Per Employee: $289.24K; $331.99K
Profits Per Employee: $16.23K; -$46.47K
Employee Count: 2,533; 193
WACC: 9.03%; 9.91%

Income statement (TTM)Industry

Revenue: $732.66M; $108.17M
Gross Profit: $308.02M; $62.29M
Operating Income: $78.74M; -$3.72M
Pretax Income: $61.34M; -$1.83M
Net Income: $41.11M; -$6.19M
EBITDA: $101.80M; -$1.98M
EPS (Diluted): $0.91; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $63.92M; $38.97M
Total Debt: $369.48M; $96.00M
Net Cash (Debt): -$305.56M; $3.95M
Net Cash Per Share: -$7.14; $0.26
Equity (Book Value): $366.78M; $63.80M
Book Value Per Share: $8.57; $3.26
Tangible Book Value: -$37.85M; $11.61M
Working Capital: $204.65M; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: $88.84M; -$483.87K
Capital Expenditures: -$12.48M; -$3.94M
Free Cash Flow: $76.36M; -$238.00K
FCF Per Share: $1.78; -$0.00

Dividends and yieldsIndustry

Earnings Yield: 2.87%; -4.76%
FCF Yield: 5.34%; 0.28%
Dividend Yield: 1.14%; 0.79%
Shareholder Yield: 1.14%; 1.12%
Dividend Per Share: $0.38; $0.72
Dividend Growth (YoY): 8.57%; 4.88%
Years of Dividend Growth: 2; 0
Payout Ratio: 40.6%; 24.3%
FCF Payout Ratio: 21.9%; 22.0%

Taxes and interestIndustry

Income Tax: $20.23M; $1.55M
Effective Tax Rate: 33.0%; 18.0%

Scores and fair valueIndustry

Graham Number: $13.24; $38.11
Graham Upside: -60.4%; -56.1%
Altman Z-Score: 2.96; 2.47
Piotroski F-Score: 5; 5
Beneish M-Score: -2.46; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CDRE	S&P 500	Difference	CDRE per year	S&P 500 per year
1 month	+27.8%	-3.0%	+30.8 pts
3 months	-1.4%	-2.8%	+1.4 pts
Year to date	-17.4%	+11.5%	−28.9 pts
1 year	-21.9%	+13.5%	−35.4 pts
3 years	+6.6%	+77.7%	−71.1 pts	+2.2%	+21.1%
5 years	+78.7%	+72.6%	+6.1 pts	+12.3%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M CDRE shares were sold short on Oct 30, 2026, up 13.8% from the previous report, or 6.93% of the shares available to trade. At recent volumes it would take 4.5 days to buy them back. Over the last 20 sessions, 42.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,147,275	+13.8%	471,799	4.5
Oct 15, 2026	1,886,616	-4.7%	587,041	3.2
Sep 30, 2026	1,979,273	-12.3%	605,757	3.3
Sep 15, 2026	2,257,405	+4.3%	355,247	6.3
Aug 31, 2026	2,164,136	-4.0%	302,118	7.2
Aug 14, 2026	2,253,943	-27.9%	474,260	4.8
Jul 31, 2026	3,127,708	+19.8%	359,105	8.7
Jul 15, 2026	2,611,230	+11.8%	260,114	10.0
Jun 30, 2026	2,336,036	+18.9%	642,730	3.6
Jun 15, 2026	1,964,087	-3.5%	299,682	6.5
May 29, 2026	2,035,735	-13.6%	279,097	7.3
May 15, 2026	2,357,329	-7.6%	549,417	4.3